Aduro BioTech's IPO

Aduro BioTech raised a round of funding on April 15, 2015. Investors include Public.

Aduro is advancing multiple therapeutic and prophylactic vaccines for cancer and infectious diseases based on its attenuated Listeria monocytogenes vaccine platforms. The company is also advancing a n…

Articles about Aduro BioTech's IPO: